BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17427007)

  • 1. [Genetic immunization: new ways for protective and therapeutic vaccines against allergic diseases].
    Scheiblhofer S; Weiss R; Thalhamer J
    Wien Med Wochenschr; 2007; 157(5-6):111-5. PubMed ID: 17427007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is genetic vaccination against allergy possible?
    Weiss R; Scheiblhofer S; Gabler M; Ferreira F; Leitner WW; Thalhamer J
    Int Arch Allergy Immunol; 2006; 139(4):332-45. PubMed ID: 16534215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
    Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
    Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases.
    Weiss R; Hammerl P; Hartl A; Hochreiter R; Leitner WW; Scheiblhofer S; Thalhamer J
    Curr Drug Targets Inflamm Allergy; 2005 Oct; 4(5):585-97. PubMed ID: 16248827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA vaccines against allergy].
    Sato Y; Kasukawa R
    Nihon Rinsho; 2000 Jun; 58(6):1307-14. PubMed ID: 10879058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-based approaches to the treatment of allergies.
    Spiegelberg HL; Raz E
    Curr Opin Mol Ther; 2002 Feb; 4(1):64-71. PubMed ID: 11883696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.
    Weinberger EE; Isakovic A; Scheiblhofer S; Ramsauer C; Reiter K; Hauser-Kronberger C; Thalhamer J; Weiss R
    Vaccine; 2013 Dec; 31(51):6113-21. PubMed ID: 23954383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.
    Scheiblhofer S; Gabler M; Leitner WW; Bauer R; Zoegg T; Ferreira F; Thalhamer J; Weiss R
    Allergy; 2006 Jul; 61(7):828-35. PubMed ID: 16792580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.
    Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G
    Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deviation of the allergic IgE to an IgG response by gene immunotherapy.
    Raz E; Spiegelberg HL
    Int Rev Immunol; 1999; 18(3):271-89. PubMed ID: 10614729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of an IgE response to bovine beta-lactoglobulin by gene immunization in mice].
    Adel-Patient K; Créminon Ch; Boquet D; Wal JM; Chatel JM
    Allerg Immunol (Paris); 2002 Mar; 34(3):77-81. PubMed ID: 12012791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination.
    Ludwig-Portugall I; Montermann E; Kremer A; Reske-Kunz AB; Sudowe S
    J Allergy Clin Immunol; 2004 Oct; 114(4):951-7. PubMed ID: 15480341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DNA vaccines to allergic diseases and upcoming clinical application].
    Sano K
    Nihon Rinsho; 2005 May; 63 Suppl 5():73-9. PubMed ID: 15954328
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy.
    Sudowe S; Montermann E; Steitz J; Tüting T; Knop J; Reske-Kunz AB
    Gene Ther; 2002 Jan; 9(2):147-56. PubMed ID: 11857073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and therapeutic DNA vaccination against allergic diseases.
    Isakovic A; Weiss R; Thalhamer J; Scheiblhofer S
    Methods Mol Biol; 2014; 1143():243-58. PubMed ID: 24715292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization.
    Spiegelberg HL; Broide D; Tighe H; Roman M; Raz E
    Pediatr Pulmonol Suppl; 1999; 18():118-21. PubMed ID: 10093118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicistronic expression plasmid encoding allergen and anti-IgE single chain variable fragment antibody as a novel DNA vaccine for allergy therapy and prevention.
    Bandbon Balenga NA; Thalhamer J; Weiss R
    Med Hypotheses; 2006; 67(1):71-4. PubMed ID: 16513289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines for allergy treatment.
    Weiss R; Scheiblhofer S; Thalhamer J
    Methods Mol Med; 2006; 127():253-67. PubMed ID: 16988459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA immunotherapeutics: new potential treatment modalities for allergic disease.
    Goodman JS; Van Uden JH; Kobayashi H; Broide D; Raz E
    Int Arch Allergy Immunol; 1998 Jul; 116(3):177-87. PubMed ID: 9693265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.